| __timestamp | Sanofi | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8565000000 | 2917513 |
| Thursday, January 1, 2015 | 9496000000 | 7878291 |
| Friday, January 1, 2016 | 9592000000 | 8366794 |
| Sunday, January 1, 2017 | 10164000000 | 6610381 |
| Monday, January 1, 2018 | 9934000000 | 6556000 |
| Tuesday, January 1, 2019 | 9883000000 | 6930000 |
| Wednesday, January 1, 2020 | 9390000000 | 8758000 |
| Friday, January 1, 2021 | 9555000000 | 10806000 |
| Saturday, January 1, 2022 | 10539000000 | 9844000 |
| Sunday, January 1, 2023 | 10765000000 | 13481000 |
| Monday, January 1, 2024 | 9183000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of industry giants and emerging players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Sanofi and Soleno Therapeutics, Inc. over the past decade, from 2014 to 2023.
Sanofi, a global leader, has consistently demonstrated robust financial management, with SG&A expenses showing a steady increase of approximately 26% over the period. In contrast, Soleno Therapeutics, Inc., a smaller entity, has seen its SG&A expenses surge by over 360%, reflecting its aggressive growth strategy.
This comparison highlights the contrasting financial strategies of a well-established pharmaceutical giant and a nimble, growth-oriented company. As the industry continues to evolve, these insights provide a window into the strategic priorities shaping the future of healthcare.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Sanofi and Alkermes plc
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Sanofi and ADMA Biologics, Inc.
Who Optimizes SG&A Costs Better? Sanofi or Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Sanofi and MiMedx Group, Inc.
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Soleno Therapeutics, Inc.
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends